Clinical Trial Update: Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update on GSK's TB vaccine in adults; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GSK TB vaccine (candidate from GlaxoSmithKline) (unknown)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis, Tuberculosis Vaccines | Phase 2 | Status: COMPLETED | Results posted: 2019-12-03